As the pharmaceutical landscape evolves, the US pharmaceutical contract manufacturing market is witnessing significant shifts in market share dynamics. The projected market size is set to reach USD 86.16 billion by the year 2035, reflecting a strong compound annual growth rate (CAGR) of 4.56%. This growth is primarily driven by the increasing trend of outsourcing manufacturing processes,...